CClinicalTrials.gg
CompletedNCT03578653MY-OT for PDUpdated Jul 25, 2019

Merging Yoga and Occupational Therapy for Parkinson Disease: Phase 2

An interventional study of Merging Yoga and Occupational Therapy for Parkinson disease in Parkinson Disease, sponsored by Colorado State University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-25.

Sponsored by Colorado State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The full program is focused on identifying and reducing risk factors surrounding falls. Based on previous research, we believe that occupational therapy group classes and adaptive yoga are an ideal pairing to reduce fall risk. The occupational therapy sessions will consist of lecture, group discussion, and activities designed to target biological, behavioral, environmental, and socioeconomic factors that contribute to fall risk specifically for people with Parkinson's disease.

02

Conditions studied

  • Parkinson Disease

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 18 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Colorado State University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Individuals with a diagnosis of Parkinson's disease OR their care partners
  • Individuals who read and understand English
  • Individuals who can stand with or without an assistive device
  • People who are willing to commit to yoga practice 2x/week for 8 weeks and pay $5/class through Raintree Athletic Club (Scholarships are available if needed!)
  • People who are willing to commit to group occupational therapy 2x/week for 8 weeks free of charge
  • score of at least 4/6 on the short mini mental status exam

Exclusion criteria

Exclusion Criteria:

  • less than 18 years of age
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    Merging Yoga and Occupational Therapy for Parkinson disease

    The group participates in three assessment periods: August, October, and December. Then in October-December the group will receive group occupational therapy and recommended community adaptive yoga programming 2x/week for 8 weeks.

    Behavioral: Merging Yoga and Occupational Therapy for Parkinson disease

Interventions

  • BehavioralMerging Yoga and Occupational Therapy for Parkinson disease

    The group occupational therapy portion focuses on lecture, group discussion, and activities to reduce fall risk. The yoga program is part of an ongoing community yoga program specifically designed for people with Parkinson disease.

06

What researchers measure

Primary outcomes

  1. Change in Fall Risk Factor Management

    Self-report 5 scales measuring the ability to manage fall risk factors

    Time frame: Baseline, Pre-assessment (8-weeks after baseline), and post-assessment (8-weeks after pre-assessment)

07

Study locations

1 site
  • Colorado State University
    Fort Collins, Colorado 80521, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03578653
Lead sponsor
Colorado State University
Responsible party
Sponsor
First posted
Jul 6, 2018
Start date
Jun 1, 2018
Primary completion
Dec 31, 2018
Completion
Mar 31, 2019
Last update
Jul 25, 2019

Study contacts

Laura Grimm, MS
principal investigator · Colorado State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion